Rush Univ. Med. Ctr. ACTG CRS — Chicago, Illinois

Rush Univ. Med. Ctr. ACTG CRS is a clinical research site located in Chicago, Illinois, United States.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Rush Univ. Med. Ctr. ACTG CRS has participated in 52 clinical trials.

Therapeutic areas: Cytomegalovirus Retinitis, HIV Infections, Sexually Transmitted Diseases.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush Univ. Med. Ctr. ACTG CRS?

Rush Univ. Med. Ctr. ACTG CRS has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush Univ. Med. Ctr. ACTG CRS conducted?

Rush Univ. Med. Ctr. ACTG CRS has 52 clinical trials on record. Their work covers Cytomegalovirus Retinitis, HIV Infections, Sexually Transmitted Diseases.

Is Rush Univ. Med. Ctr. ACTG CRS accredited by Crixeo Health?

Yes — Rush Univ. Med. Ctr. ACTG CRS holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rush Univ. Med. Ctr. ACTG CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.